| # | Drug | Count |
|---|---|---|
| 0 | LEVONORGESTREL | 105 |
| 1 | COPPER | 48 |
| 2 | ADALIMUMAB | 39 |
| 3 | RIVAROXABAN | 28 |
| 4 | INTERFERON BETA-1A | 23 |
| 5 | WARFARIN | 21 |
| 6 | ASPIRIN | 16 |
| 7 | ASPIRIN 325 MG | 16 |
| 8 | ASPIRIN 81 MG | 16 |
| 9 | FOLIC ACID | 16 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ASCORBIC ACID, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL ACETATE, D-, THIAMINE HYDROCHLORIDE, RIBOFLAVIN, NIACIN, PYRIDOXINE HYDROCHLORIDE, LEVOMEFOLATE MAGNESIUM, FOLIC ACID, CYANOCOBALAMIN, IRON PENTACARBONYL, POTASSIUM IODIDE, MAGNESIUM OXIDE, DOCONEXENT, AND ICOSAPENT | 1 | 0.1667 |
| 1 | VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) | 2 | 0.0130 |
| 2 | CHORIONIC GONADOTROPIN | 4 | 0.0071 |
| 3 | CLOMIPHENE CITRATE | 9 | 0.0060 |
| 4 | ULIPRISTAL ACETATE | 2 | 0.0039 |
| 5 | GONADOTROPHIN, CHORIONIC | 2 | 0.0032 |
| 6 | MENOTROPINS | 7 | 0.0032 |
| 7 | GANIRELIX ACETATE | 2 | 0.0026 |
| 8 | FOLLITROPIN ALFA | 5 | 0.0024 |
| 9 | INFLIXIMAB-DYYB | 7 | 0.0020 |
| # | Drug class | Count |
|---|---|---|
| 0 | Progestin [EPC] | 120 |
| 1 | Progestin-containing Intrauterine System [EPC] | 105 |
| 2 | Copper-containing Intrauterine Device [EPC] | 48 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 41 |
| 4 | Corticosteroid [EPC] | 32 |
| 5 | Factor Xa Inhibitor [EPC] | 28 |
| 6 | Tumor Necrosis Factor Blocker [EPC] | 26 |
| 7 | Interferon beta [EPC] | 23 |
| 8 | Benzodiazepine [EPC] | 22 |
| 9 | Vitamin C [EPC] | 19 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Antihemophilic Factor [EPC] | 2 | 0.0130 |
| 1 | Human Blood Coagulation Factor [EPC] | 2 | 0.0024 |
| 2 | Sclerosing Agent [EPC] | 1 | 0.0022 |
| 3 | Gonadotropin [EPC] | 4 | 0.0018 |
| 4 | Serotonin-4 Receptor Agonist [EPC] | 1 | 0.0015 |
| 5 | CD33-directed Immunoconjugate [EPC] | 4 | 0.0011 |
| 6 | Copper-containing Intrauterine Device [EPC] | 48 | 0.0010 |
| 7 | Progestin [EPC] | 120 | 0.0004 |
| 8 | Anthelmintic [EPC] | 1 | 0.0003 |
| 9 | Vitamin D3 Analog [EPC] | 5 | 0.0002 |